Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Our understanding of the pathogenic role of IgE in atopic dermatitis is incomplete.
We asked whether blocking free IgE would alter the course of the disease.
Title:
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society
of Dermatology : JDDG
ISSN
(Electronic):
1610-0387
ISSN
(Print):
1610-0379
Publication date
(Electronic):
Dec 2010
Volume: 8
Issue: 12
Affiliations
[1
]
Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology,
Medical University of Vienna, Austria. peter.heil@meduniwien.ac.at